Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
Randomized Phase II Study of Two Schedules of Flavopiridol (Alvocidib, F) Given as Timed Sequential Therapy (TST) Wtih Ara-C and Mitoxantrone (FLAM) for Adults with Newly Diagnosed, Poor-Risk Acute Myelogenous Leukemia (AML)
Blood (2010)
  • Judith E. Karp, Johns Hopkins University
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • B. Douglas Smith, Johns Hopkins University
  • Jacqueline M Greer, Johns Hopkins University
  • D. Michelle Drye, Johns Hopkins University
  • Kelly M. Smith, University of Washington Medical Center
  • Kathleen Dorcy, University of Washington
  • John J Wright, National Institutes of Health
  • L. Austin Doyle, National Institutes of Health
  • Elizabeth Garrett-Mayer, Medical University of South Carolina
  • Elihu H. Estey, Fred Hutchinson Cancer Research Center
Link
Disciplines
Publication Date
November 19, 2010
Citation Information
Judith E. Karp, John M. Pagel, B. Douglas Smith, Jacqueline M Greer, et al.. "Randomized Phase II Study of Two Schedules of Flavopiridol (Alvocidib, F) Given as Timed Sequential Therapy (TST) Wtih Ara-C and Mitoxantrone (FLAM) for Adults with Newly Diagnosed, Poor-Risk Acute Myelogenous Leukemia (AML)" Blood Vol. 116 Iss. 21 (2010) p. 186 - 186
Available at: http://works.bepress.com/john-pagel/192/